Navigation Links
CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
Date:9/19/2007

KIRKLAND, Wash., Sept. 19 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (the "Company") (OTC Bulletin Board: CCYG) has formed a new Device Division in order to develop, manufacture and market its patented line of stem cell cultivation and replication devices.

CellCyte Genetics is developing stem cell enabling therapeutic products designed to allow more efficient delivery and significantly increased retention of adult stem cells to diseased organs, such as the heart.

Along with its planned human trials for its therapeutics, CellCyte Genetics intends to develop a new stem cell cultivation device or "bioreactor" unit for which CellCyte Genetics owns the worldwide patent and rights. The Company plans to market the device for applications that will require cells to be grown under regulated oxygen concentrations, e.g. the replication of stem cells and the culture of pancreatic islet cells prior to transplantation into diabetic patients.

Dr. Ron Berninger, Chief Scientific Officer of CellCyte Genetics explains, "CellCyte's patented biological cell maintenance system has the unique ability to incubate cultured cells with a very efficient and regulatable oxygen supply, making it an ideal choice for culturing cells that are otherwise difficult to keep alive or to expand. Inside the bioreactor, the cells can also form a 3-dimensional network, which is what most cell types do in major organs of the body."

A key element of this bioreactor is the capability to supply oxygen (by bundles of oxygen fibers) to the cells throughout the entire space in which cells are growing. Stem cells appear to be sensitive to oxygen levels and can be induced to replicate or differentiate in part by controlling the oxygen level.

Using CellCyte's product, scientists, researchers and clinicians should be able to dramatically increase the number of stem cells available for research and potentially for use in stem cell therapies. Management believes that th
'/>"/>

SOURCE CellCyte Genetics Corporation
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related biology technology :

1. Wisconsin court affirms damages in Innogenetics, Abbott patent case
2. Third Wave licenses Innogenetics tech to settle lawsuit
3. Symposium examines the effect of race on genetics and disease
4. Metavante Corp. will continue M&A activity
5. Lucigen Corp. enters global licensing agreement
6. CIO Leadership Series: Jane Durment, Marcus Corp.
7. Brady Corp. acquires Korean counterpart
8. Brady Corp. raises $137 million in public offering
9. Symphony Corp. and CareEvolution to partner
10. RedPrairie Corp. introduces new supply chain software
11. California investors acquire RedPrairie Corp.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotech ...accines, announced today that it executed,a joint ...n) Vaccine,Technology Co., Ltd. (Sinovac Dalian). ...ialize human-use vaccines. Sinovac will contribute...mmercializing world-class vaccines; the,other part...
(Date:11/24/2009)...v. 24 IES (Nasdaq: IESC...communications systems and services for the commer...d today that its commercial business group has bee...nstall the electrical systems for the Level 4 bio-.... Army Medical Research Institute of Infectious Di...
(Date:11/24/2009)...NHEIM, Ontario, Nov. 24 ...iring the assets of Hyland Seeds, a division of Th... of Hyland Seeds will further expand Dow AgroScien...ates the introduction of SmartStax(TM) in 2010...echnology in corn in 2012. The transactional close...
(Date:11/24/2009)... REYKJAVIK, Iceland, November 24 /PRNewswire-Firs...day announced the approval of all of its,"first da...strict of Delaware,(the "Bankruptcy Court"). deCOD...under Chapter 11 of the United States Bankruptcy C...rs issued by the Bankruptcy Court allow the compan...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...alth-care professionals received advice about inte...l Healthcare Conference, held June 8-9 at the Flun...discussed technologies which have worked in clinic...s well as the multiple roadblocks to successful im...n the fact that technology for technology,s sake i...
...s, Canada is the 51st state to the north. The cou... not information technology. , ,In fact, Vancouve... development environment, and I was lucky enough t...meeting with some very savvy developers. Over the ...mpanies I met there. , , Imagis Technologies is a ...
Healthcare providers to merge under one name
Other Biology Technology:Digitizing hospitals with the right tools 2Digitizing hospitals with the right tools 3Digitizing hospitals with the right tools 4Imagis emerges from bumpy road 2Imagis emerges from bumpy road 3
(Date:11/24/2009)..., BATON ROUGE Antarctica has long held secrets o...d until recently, there has been very little infor...eneath miles of ice for millions of years. Now, a ...ing LSU have been funded to the tune of $10 milli...NSF, to get to the bottom of things literally. Th...
(Date:11/23/2009)... CINCINNATINew research presents strong evidence t...e to both outdoor traffic-related pollution and in...s than one or the other exposure alone. , Envi...incinnati (UC) College of Medicine have shown that...elated particles and indoor endotoxin during early...
(Date:11/23/2009)..., A new study by the Wildlife Conservation Societ...arge swamp in the Republic of Congopart of the "mo...d last yearare becoming increasingly threatened by...udy recommends protection of the swamp forests adj...Reserve after recent surveys confirmed that high d...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Mexico Premiere for Money Saving Pharma Leak Testing Equipment 12573 1Mexico Premiere for Money Saving Pharma Leak Testing Equipment 12573 2Mexico Premiere for Money Saving Pharma Leak Testing Equipment 12573 3Clearly Contacts Announces Another Quarter Of Growth In The Economic Downturn 48555 1Clearly Contacts Announces Another Quarter Of Growth In The Economic Downturn 48555 2Clearly Contacts Announces Another Quarter Of Growth In The Economic Downturn 48555 3Omega 3 EPA 3A Treatment for a Heart Condition 48552 1Omega 3 EPA 3A Treatment for a Heart Condition 48552 2Omega 3 EPA 3A Treatment for a Heart Condition 48552 3Omega 3 EPA 3A Treatment for a Heart Condition 48552 4Omega 3 EPA 3A Treatment for a Heart Condition 48552 5Omega 3 EPA 3A Treatment for a Heart Condition 48552 6
...rcher suggests a new avenue for developing a vacci...d by herpes simplex viruses. , In a study publish...virologist William Halford showed that mice vaccin...lex virus type 1 (HSV-1) showed no signs of diseas...thal "wild-type" strain of the virus. , In contr...
...loped two new technologies for measuring cell grow...echnology provides a way for researchers to easily...ding to an anti-cancer drug. The second -- because...for the simultaneous testing of different dosages,... of cells taken from the body. , Shang-Tian Yang,...
...prominently in meeting transportation fuel needs, ...-growing poplar tree is featured on the cover of t...rticle, highlighting the analysis of the first com... or Populus trichocarpa, lays the groundwork that ...feedstock" for a new generation of biofuels such a...
Other Biology News:Research holds promise for herpes vaccine 2Chemical tests of cell growth enter third dimension 2Chemical tests of cell growth enter third dimension 3The first tree genome is published: Poplar holds promise as renewable bioenergy resource 2The first tree genome is published: Poplar holds promise as renewable bioenergy resource 3The first tree genome is published: Poplar holds promise as renewable bioenergy resource 4
...es optimized reagents and protocols for the rapid ...rtion of group II introns. The method exploits the...zes a simple PCR step to re-target the TargeTron g...t genome. Utility of the technology has been demon...
Mouse Anti-Human PPIL2 Monoclonal Antibody, Unconjugated, Clone 2E11 from Abnova Corporation
Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Abnova Corporation
Mouse Anti-IFNA2 Monoclonal Antibody, Unconjugated, Clone 1F11 from Abnova Corporation
Biology Products: